Cataracts, the loss of lens transparency, are the leading cause of human blindness. The zebrafish embryo, with its transparency and relatively large eyes, is an excellent model for studying ocular disease in vivo. We found that the zebrafish cloche mutant, both the cloche m39 and cloche S5 alleles, which have defects in hematopoiesis and blood vessel development, also have lens cataracts. Quantitative examination of the living zebrafish lens by confocal microscopy showed significant increases in lens reflectance. Histological analysis revealed retention of lens fiber cell nuclei owing to impeded terminal differentiation. Proteomics identified ␥-crystallin as a protein that was substantially diminished in cloche mutants. Crystallins are the major structural proteins in mouse, human and zebrafish lens. Defects in crystallins have previously been shown in mice and humans to contribute to cataracts. The loss of ␥-crystallin protein in cloche was not due to lowered mRNA levels but rather to ␥-crystallin protein insolubility. ␣A-crystallin is a chaperone that protects proteins from misfolding and becoming insoluble. The cloche lens is deficient in both ␣A-crystallin mRNA and protein during development from 2-5 dpf. Overexpression of exogenous ␣A-crystallin rescued the cloche lens phenotype, including solubilization of ␥-crystallin, increased lens transparency and induction of lens fiber cell differentiation. Taken together, these results indicate that ␣A-crystallin expression is required for normal lens development and demonstrate that cataract formation can be prevented in vivo. In addition, these results show that proteomics is a valuable tool for detecting protein alterations in zebrafish.